WQ97452 (e) Tabled on 23/09/2025

What plans does the Cabinet Secretary have to ensure equitable access to calcitonin gene-related peptide monoclonal antibodies and calcitonin gene-related peptide receptor antagonists for migraine treatment across Wales?

To be answered by: Cabinet Secretary for Health and Social Care